Search Results for keywords:"suspicious orders report system"

Search Results: keywords:"suspicious orders report system"

S. 5271 — To require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency.
September 25, 2024
Status:Introduced in Senate
Congress:118
Words:510
S. 5271, also known as the “BUPE for Recovery Act,” proposes that the Drug Enforcement Administration (DEA) exempt buprenorphine—a medication used for opioid addiction treatment—from being flagged in the Suspicious Orders Report System during the ongoing opioid public health...
Simple Explanation
S. 5271 wants to make it easier for people to get special medicine called buprenorphine, which helps people stop taking harmful drugs, by removing some red tape rules for a while. This will be tested to see if it helps more people get the medicine they need.
H. R. 9886 — To require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency.
September 27, 2024
Status:Introduced in House
Congress:118
Words:548
H. R. 9886, known as the “Broadening Utilization of Proven and Effective Treatment for Recovery Act” or the “BUPE for Recovery Act,” proposes to temporarily exempt buprenorphine from the DEA's Suspicious Orders Report System during the ongoing opioid public health emergency....
Simple Explanation
The "BUPE for Recovery Act" is like a temporary rule that helps doctors and pharmacies give out a medicine called buprenorphine, which helps people who are sick from taking too many bad drugs, without as many checks and reports during a special health emergency. This makes it easier and faster for people to get the medicine they need to feel better.

Showing 1 to 2 of 2 results